Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 10Recruiting 3Unknown 2Terminated 2Not yet recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Breast 3Lymphoid 2CNS 2Plasma cell 1Other hematologic neoplasm 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 1774Triple Negative Breast Neoplasms 299Ovarian Neoplasms 135Lung Neoplasms 115Colorectal Neoplasms 115Neoplasms 106Prostatic Neoplasms 102Carcinoma, Non-Small-Cell Lung 101Neoplasm Metastasis 96Stomach Neoplasms 81Pancreatic Neoplasms 78Melanoma 74Endometrial Neoplasms 64Head and Neck Neoplasms 60Uterine Cervical Neoplasms 56Squamous Cell Carcinoma of Head and Neck 50Colonic Neoplasms 45Esophageal Neoplasms 42Carcinoma, Intraductal, Noninfiltrating 41Sarcoma 40Motor Activity 37HER2-positive Breast Cancer 34Urinary Bladder Neoplasms 33Liver Neoplasms 31Carcinoma, Renal Cell 30Brain Neoplasms 28Advanced Breast Cancer 25Lymphedema 24Kidney Neoplasms 24Carcinoma, Transitional Cell 23

Interventions

trastuzumab deruxtecan 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Drug-Related Side Effects and Adverse Reactions × Breast × Clear all
NCT07582887 2026-05-13

Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response

Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental

Recruiting
70 enrolled
Breast

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT07524829 2026-04-13

Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients

Azienda Sanitaria Locale di Asti

Phase NA Recruiting
124 enrolled
Breast

Treatment Adherence and Compliance, Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT03711110 2025-03-21

CARTIER

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

Phase NA Recruiting
514 enrolled
BreastGastrointestinalLymphoidPlasma cell

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Radiation Injuries, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡